Bradycor bradykinin antagonist: Filed IND

Cortech Inc. (CRTQ), Denver Product: Bradycor bradykinin antagonist Indication: Systemic inflammatory response syndrome and suspected sepsis Status: Filed IND to test seven-day infusion in a Phase II ...